Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis.
Identifieur interne : 003C84 ( Ncbi/Curation ); précédent : 003C83; suivant : 003C85Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis.
Auteurs : Masayuki Kubo [Japon] ; Tao-Sheng Li ; Takahiro Kamota ; Mako Ohshima ; Bungo Shirasawa ; Kimikazu HamanoSource :
- Journal of vascular surgery [ 1097-6809 ] ; 2010.
Descripteurs français
- KwdFr :
- Animaux, Facteur de croissance endothéliale vasculaire de type C (métabolisme), Facteurs temps, Immunohistochimie, Lapins, Lithotritie, Lymphangiogenèse, Lymphoedème (), Lymphoedème (métabolisme), Lymphoedème (physiopathologie), Lymphoedème (étiologie), Modèles animaux de maladie humaine, Mâle, Oreille, Récepteur-3 au facteur croissance endothéliale vasculaire (métabolisme), Régulation positive, Vaisseaux lymphatiques (métabolisme), Vaisseaux lymphatiques (physiopathologie).
- MESH :
- métabolisme : Facteur de croissance endothéliale vasculaire de type C, Lymphoedème, Récepteur-3 au facteur croissance endothéliale vasculaire, Vaisseaux lymphatiques.
- physiopathologie : Lymphoedème, Vaisseaux lymphatiques.
- étiologie : Lymphoedème.
- Animaux, Facteurs temps, Immunohistochimie, Lapins, Lithotritie, Lymphangiogenèse, Lymphoedème, Modèles animaux de maladie humaine, Mâle, Oreille, Régulation positive.
English descriptors
- KwdEn :
- Animals, Disease Models, Animal, Ear, Immunohistochemistry, Lithotripsy, Lymphangiogenesis, Lymphatic Vessels (metabolism), Lymphatic Vessels (physiopathology), Lymphedema (etiology), Lymphedema (metabolism), Lymphedema (physiopathology), Lymphedema (therapy), Male, Rabbits, Time Factors, Up-Regulation, Vascular Endothelial Growth Factor C (metabolism), Vascular Endothelial Growth Factor Receptor-3 (metabolism).
- MESH :
- chemical , metabolism : Vascular Endothelial Growth Factor C, Vascular Endothelial Growth Factor Receptor-3.
- etiology : Lymphedema.
- metabolism : Lymphatic Vessels, Lymphedema.
- physiopathology : Lymphatic Vessels, Lymphedema.
- therapy : Lymphedema.
- Animals, Disease Models, Animal, Ear, Immunohistochemistry, Lithotripsy, Lymphangiogenesis, Male, Rabbits, Time Factors, Up-Regulation.
Abstract
Although secondary lymphedema is a common complication after surgical and radiation therapy for cancer, the treatment options for lymphedema remain limited and largely ineffective. We thus studied the effect of extracorporeal shock wave therapy on promoting lymphangiogenesis and improving secondary lymphedema.
DOI: 10.1016/j.jvs.2010.03.017
PubMed: 20670777
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002973
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :002973
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002973
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :003C84
Links to Exploration step
pubmed:20670777Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis.</title><author><name sortKey="Kubo, Masayuki" sort="Kubo, Masayuki" uniqKey="Kubo M" first="Masayuki" last="Kubo">Masayuki Kubo</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi</wicri:regionArea><wicri:noRegion>Yamaguchi</wicri:noRegion></affiliation></author><author><name sortKey="Li, Tao Sheng" sort="Li, Tao Sheng" uniqKey="Li T" first="Tao-Sheng" last="Li">Tao-Sheng Li</name></author><author><name sortKey="Kamota, Takahiro" sort="Kamota, Takahiro" uniqKey="Kamota T" first="Takahiro" last="Kamota">Takahiro Kamota</name></author><author><name sortKey="Ohshima, Mako" sort="Ohshima, Mako" uniqKey="Ohshima M" first="Mako" last="Ohshima">Mako Ohshima</name></author><author><name sortKey="Shirasawa, Bungo" sort="Shirasawa, Bungo" uniqKey="Shirasawa B" first="Bungo" last="Shirasawa">Bungo Shirasawa</name></author><author><name sortKey="Hamano, Kimikazu" sort="Hamano, Kimikazu" uniqKey="Hamano K" first="Kimikazu" last="Hamano">Kimikazu Hamano</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:20670777</idno><idno type="pmid">20670777</idno><idno type="doi">10.1016/j.jvs.2010.03.017</idno><idno type="wicri:Area/PubMed/Corpus">002973</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002973</idno><idno type="wicri:Area/PubMed/Curation">002973</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002973</idno><idno type="wicri:Area/PubMed/Checkpoint">002973</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002973</idno><idno type="wicri:Area/Ncbi/Merge">003C84</idno><idno type="wicri:Area/Ncbi/Curation">003C84</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis.</title><author><name sortKey="Kubo, Masayuki" sort="Kubo, Masayuki" uniqKey="Kubo M" first="Masayuki" last="Kubo">Masayuki Kubo</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi</wicri:regionArea><wicri:noRegion>Yamaguchi</wicri:noRegion></affiliation></author><author><name sortKey="Li, Tao Sheng" sort="Li, Tao Sheng" uniqKey="Li T" first="Tao-Sheng" last="Li">Tao-Sheng Li</name></author><author><name sortKey="Kamota, Takahiro" sort="Kamota, Takahiro" uniqKey="Kamota T" first="Takahiro" last="Kamota">Takahiro Kamota</name></author><author><name sortKey="Ohshima, Mako" sort="Ohshima, Mako" uniqKey="Ohshima M" first="Mako" last="Ohshima">Mako Ohshima</name></author><author><name sortKey="Shirasawa, Bungo" sort="Shirasawa, Bungo" uniqKey="Shirasawa B" first="Bungo" last="Shirasawa">Bungo Shirasawa</name></author><author><name sortKey="Hamano, Kimikazu" sort="Hamano, Kimikazu" uniqKey="Hamano K" first="Kimikazu" last="Hamano">Kimikazu Hamano</name></author></analytic><series><title level="j">Journal of vascular surgery</title><idno type="eISSN">1097-6809</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Disease Models, Animal</term><term>Ear</term><term>Immunohistochemistry</term><term>Lithotripsy</term><term>Lymphangiogenesis</term><term>Lymphatic Vessels (metabolism)</term><term>Lymphatic Vessels (physiopathology)</term><term>Lymphedema (etiology)</term><term>Lymphedema (metabolism)</term><term>Lymphedema (physiopathology)</term><term>Lymphedema (therapy)</term><term>Male</term><term>Rabbits</term><term>Time Factors</term><term>Up-Regulation</term><term>Vascular Endothelial Growth Factor C (metabolism)</term><term>Vascular Endothelial Growth Factor Receptor-3 (metabolism)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Facteur de croissance endothéliale vasculaire de type C (métabolisme)</term><term>Facteurs temps</term><term>Immunohistochimie</term><term>Lapins</term><term>Lithotritie</term><term>Lymphangiogenèse</term><term>Lymphoedème ()</term><term>Lymphoedème (métabolisme)</term><term>Lymphoedème (physiopathologie)</term><term>Lymphoedème (étiologie)</term><term>Modèles animaux de maladie humaine</term><term>Mâle</term><term>Oreille</term><term>Récepteur-3 au facteur croissance endothéliale vasculaire (métabolisme)</term><term>Régulation positive</term><term>Vaisseaux lymphatiques (métabolisme)</term><term>Vaisseaux lymphatiques (physiopathologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Vascular Endothelial Growth Factor C</term><term>Vascular Endothelial Growth Factor Receptor-3</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Lymphatic Vessels</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Facteur de croissance endothéliale vasculaire de type C</term><term>Lymphoedème</term><term>Récepteur-3 au facteur croissance endothéliale vasculaire</term><term>Vaisseaux lymphatiques</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Lymphoedème</term><term>Vaisseaux lymphatiques</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Lymphatic Vessels</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Disease Models, Animal</term><term>Ear</term><term>Immunohistochemistry</term><term>Lithotripsy</term><term>Lymphangiogenesis</term><term>Male</term><term>Rabbits</term><term>Time Factors</term><term>Up-Regulation</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Facteurs temps</term><term>Immunohistochimie</term><term>Lapins</term><term>Lithotritie</term><term>Lymphangiogenèse</term><term>Lymphoedème</term><term>Modèles animaux de maladie humaine</term><term>Mâle</term><term>Oreille</term><term>Régulation positive</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Although secondary lymphedema is a common complication after surgical and radiation therapy for cancer, the treatment options for lymphedema remain limited and largely ineffective. We thus studied the effect of extracorporeal shock wave therapy on promoting lymphangiogenesis and improving secondary lymphedema.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003C84 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 003C84 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:20670777
|texte= Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:20670777" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |